Latest Stories
3 Reasons to Avoid HAE and 1 Stock to Buy Instead
Haemonetics has gotten torched over the last six months - since October 2024, its stock price has dropped 20.1% to $63.39 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Winners And Losers Of Q4: BJ's (NASDAQ:BJRI) Vs The Rest Of The Sit-Down Dining Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the sit-down dining industry, including BJ's (NASDAQ:BJRI) and its peers.
Spotting Winners: APi (NYSE:APG) And Construction and Maintenance Services Stocks In Q4
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the construction and maintenance services industry, including APi (NYSE:APG) and its peers.
2 Reasons to Sell PRVA and 1 Stock to Buy Instead
Even during a down period for the markets, Privia Health has gone against the grain, climbing to $22.91. Its shares have yielded a 29.3% return over the last six months, beating the S&P 500 by 30.9%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Collegium Pharmaceutical (NASDAQ:COLL) and the rest of the branded pharmaceuticals stocks fared in Q4.
Waste Management (WM): Buy, Sell, or Hold Post Q4 Earnings?
While the broader market has struggled with the S&P 500 down 1.7% since October 2024, Waste Management has surged ahead as its stock price has climbed by 13% to $234.23 per share. This performance may have investors wondering how to approach the situation.
3 Reasons to Sell WYNN and 1 Stock to Buy Instead
Over the past six months, Wynn Resorts’s shares (currently trading at $83.10) have posted a disappointing 18.6% loss while the S&P 500 was down 1.7%. This may have investors wondering how to approach the situation.
2 Reasons to Watch KRT and 1 to Stay Cautious
Karat Packaging has been treading water for the past six months, recording a small return of 4.2% while holding steady at $26.44. However, the stock is beating the S&P 500’s 1.7% decline during that period.
Winners And Losers Of Q4: CBRE (NYSE:CBRE) Vs The Rest Of The Real Estate Services Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how real estate services stocks fared in Q4, starting with CBRE (NYSE:CBRE).
Q4 Rundown: Elevance Health (NYSE:ELV) Vs Other Health Insurance Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Elevance Health (NYSE:ELV) and the rest of the health insurance providers stocks fared in Q4.